Cardiovascular risk and all-cause mortality attributable to diabetes: Tehran Lipid and Glucose Study

被引:0
作者
M. Bozorgmanesh
F. Hadaegh
F. Sheikholeslami
F. Azizi
机构
[1] Shahid Beheshti University of Medical Sciences,Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences
来源
Journal of Endocrinological Investigation | 2012年 / 35卷
关键词
All-cause mortality; cardiovascular disease; diabetes; population attributable fraction; risk;
D O I
暂无
中图分类号
学科分类号
摘要
Aim: To quantify the burden of cardiovascular diseases (CVD), and all-cause mortality attributable to diabetes. Subjects and methods: Data on an 8.6-yr follow-up of 6331 participants (2741 men), free of CVD at baseline, were analyzed to determine the burden of CVD and all-cause mortality attributable to self-reported and screen-detected diabetes mellitus (SRDM and SDDM, respectively). Risks of events of interest were separately assessed for women and men using Cox-proportional-hazard model. Results: The mean age at baseline was 47 yr with 997 (15.7%) of participants having diabetes (men 14.8%, women 16.5%). SRDM and SDDM prevailed in 9.7% (men 9.2, women 10.2%) and 6.0% of participants (men 5.7, women 6.3%), respectively. During follow up (52,404 person-yr), we observed 447 incident cases of CVD [387 had coronary heart disease (CHD)] and 209 deaths. Among men, participants with SDDM had increased relative hazard for all-cause mortality translated to a population attributable risk fraction (PAF) of 10.1%. Among women, SDDM was associated with CVD and CHD but not with all-cause mortality; so that 9.3% and 8.8% of CVD and CHD events were respectively attributable to the SDDM. If SRDM had been eliminated from the population, the incidences of CVD, CHD, and death would have decreased by 10.5, 9.5, and 17.3% in men; and 22.0, 24.2, and 17.8% in women, respectively. Conclusion: SDDM and SRDM have high PAF for all-cause mortality and CVD. Besides diabetes treatment and prevention, screening to detect undiagnosed diabetes should warrant high priority among the public health strategies to lower the incidence of CVD and mortality.
引用
收藏
页码:14 / 20
页数:6
相关论文
共 50 条
  • [31] Adherence to a Healthy Lifestyle and the Risk of All-Cause Mortality and Cardiovascular Events in Individuals With Diabetes: The ARIC Study
    Li, Dongze
    Jia, Yu
    Yu, Jing
    Liu, Yi
    Li, Fanghui
    Liu, Yanmei
    Wu, Qinqin
    Liao, Xiaoyang
    Zeng, Zhi
    Wan, Zhi
    Zeng, Rui
    [J]. FRONTIERS IN NUTRITION, 2021, 8
  • [32] Body mass index and risk of all-cause and cardiovascular mortality in hospitalized elderly patients with diabetes mellitus
    Weiss, A.
    Boaz, M.
    Beloosesky, Y.
    Kornowski, R.
    Grossman, E.
    [J]. DIABETIC MEDICINE, 2009, 26 (03) : 253 - 259
  • [33] Fasting glucose variability in young adulthood and incident diabetes, cardiovascular disease and all-cause mortality
    Michael P. Bancks
    April P. Carson
    Cora E. Lewis
    Erica P. Gunderson
    Jared P. Reis
    Pamela J. Schreiner
    Yuichiro Yano
    Mercedes R. Carnethon
    [J]. Diabetologia, 2019, 62 : 1366 - 1374
  • [34] QRS duration is associated with all-cause mortality in type 2 diabetes: The diabetes heart study
    Singleton, Matthew J.
    German, Charles
    Hari, Krupal J.
    Saylor, Georgia
    Herrington, David M.
    Soliman, Elsayed Z.
    Freedman, Barry, I
    Bowden, Donald W.
    Bhave, Prashant D.
    Yeboah, Joseph
    [J]. JOURNAL OF ELECTROCARDIOLOGY, 2020, 58 : 150 - 154
  • [35] Thigh Circumference and Risk of All-Cause, Cardiovascular and Cerebrovascular Mortality: A Cohort Study
    Chen, Chao-lei
    Liu, Lin
    Huang, Jia-yi
    Yu, Yu-ling
    Shen, Geng
    Lo, Kenneth
    Huang, Yu-qing
    Feng, Ying-qing
    [J]. RISK MANAGEMENT AND HEALTHCARE POLICY, 2020, 13 : 1977 - 1987
  • [36] Age of onset of diabetes and all-cause mortality
    Ang, Gary Yee
    [J]. WORLD JOURNAL OF DIABETES, 2020, 11 (04) : 95 - 99
  • [37] Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer
    Holden, S. E.
    Jenkins-Jones, S.
    Morgan, C. Ll.
    Schernthaner, G.
    Currie, C. J.
    [J]. DIABETES OBESITY & METABOLISM, 2015, 17 (04) : 350 - 362
  • [38] Association between educational level and cardiovascular disease and all-cause mortality in patients with type 2 diabetes: a prospective study in the Joint Asia Diabetes Evaluation Program
    Wu, Hongjiang
    Lau, Eric S. H.
    Kong, Alice P. S.
    Ma, Ronald C. W.
    Ozaki, Risa
    Cheung, Kitty K. T.
    Chow, Elaine
    Tsang, Chiu Chi
    Lau, Kam Piu
    Hui, Eric M. T.
    So, Wing Yee
    Gasevic, Danijela
    Wild, Sarah H.
    Chan, Juliana C. N.
    Luk, Andrea
    [J]. CLINICAL EPIDEMIOLOGY, 2018, 10 : 1561 - 1571
  • [39] Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetes
    Orsi, Emanuela
    Solini, Anna
    Bonora, Enzo
    Vitale, Martina
    Garofolo, Monia
    Fondelli, Cecilia
    Trevisan, Roberto
    Vedovato, Monica
    Cavalot, Franco
    Zerbini, Gianpaolo
    Nicolucci, Antonio
    Pugliese, Giuseppe
    [J]. DIABETES & METABOLISM, 2023, 49 (02)
  • [40] Fasting blood glucose level and risk of all-cause and cause-specific mortality in peritoneal dialysis patients
    Lim, So Jin
    Moon, Ju Young
    Jeong, Kyung Hwan
    Ko, Gang Jee
    Choi, Yun Jin
    Hwang, Hyeon Seok
    [J]. JOURNAL OF DIABETES, 2024, 16 (09)